Lantheus Holdings (LNTH) | Financial Analysis & Statements
Lantheus Holdings Inc. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
406.8M
Gross Profit
240.9M
59.21%
Operating Income
77.2M
18.97%
Net Income
54.1M
13.30%
EPS (Diluted)
$0.82
Balance Sheet Metrics
Total Assets
2.2B
Total Liabilities
1.1B
Shareholders Equity
1.1B
Debt to Equity
1.04
Cash Flow Metrics
Operating Cash Flow
63.6M
Free Cash Flow
81.4M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Lantheus Holdings Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.5B | 1.5B | 1.3B | 935.1M | 425.2M |
| Cost of Goods Sold | 599.7M | 545.6M | 586.9M | 353.4M | 237.5M |
| Gross Profit | 942.0M | 988.3M | 709.5M | 581.7M | 187.7M |
| Gross Margin % | 61.1% | 64.4% | 54.7% | 62.2% | 44.1% |
| Operating Expenses | |||||
| Research & Development | 177.3M | 168.1M | 77.7M | 311.7M | 45.0M |
| Selling, General & Administrative | 453.8M | 371.6M | 267.2M | 233.8M | 218.8M |
| Other Operating Expenses | -4.7M | - | - | - | - |
| Total Operating Expenses | 626.4M | 539.7M | 344.9M | 545.5M | 263.8M |
| Operating Income | 315.6M | 448.6M | 364.6M | 36.2M | -76.1M |
| Operating Margin % | 20.5% | 29.2% | 28.1% | 3.9% | -17.9% |
| Non-Operating Items | |||||
| Interest Income | 23.4M | 36.8M | 19.6M | 2.6M | 45.0K |
| Interest Expense | 19.7M | 19.7M | 20.0M | 7.2M | 7.8M |
| Other Non-Operating Income | -5.4M | -34.8M | 46.7M | -4.9M | 8.8M |
| Pre-tax Income | 313.8M | 431.0M | 410.9M | 26.7M | -75.0M |
| Income Tax | 80.2M | 118.5M | 84.3M | -1.3M | -3.8M |
| Effective Tax Rate % | 25.6% | 27.5% | 20.5% | -5.0% | 0.0% |
| Net Income | 233.6M | 312.4M | 326.7M | 28.1M | -71.3M |
| Net Margin % | 15.2% | 20.4% | 25.2% | 3.0% | -16.8% |
| Key Metrics | |||||
| EBITDA | 409.0M | 551.0M | 444.2M | 86.7M | -33.8M |
| EPS (Basic) | $3.46 | $4.52 | $4.79 | $0.41 | $-1.06 |
| EPS (Diluted) | $3.41 | $4.36 | $4.65 | $0.40 | $-1.06 |
| Basic Shares Outstanding | 67489000 | 69199000 | 68266000 | 68487000 | 67486000 |
| Diluted Shares Outstanding | 67489000 | 69199000 | 68266000 | 68487000 | 67486000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Lantheus Holdings Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 359.1M | 912.8M | 713.7M | 415.7M | 98.5M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 358.6M | 321.3M | 284.3M | 213.4M | 89.3M |
| Inventory | 64.7M | 68.0M | 64.0M | 35.5M | 35.1M |
| Other Current Assets | 650.0K | 9.1M | 246.0K | 205.0K | 2.7M |
| Total Current Assets | 900.0M | 1.3B | 1.1B | 677.6M | 235.8M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 31.0M | 36.1M | 45.3M | 19.0M | 8.8M |
| Goodwill | 1.2B | 284.1M | 274.4M | 437.7M | 470.9M |
| Intangible Assets | 722.8M | 161.8M | 152.0M | 315.3M | 348.5M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 128.3M | 178.4M | 160.1M | 126.0M | 92.7M |
| Total Non-Current Assets | 1.3B | 653.7M | 565.3M | 643.6M | 628.0M |
| Total Assets | 2.2B | 2.0B | 1.7B | 1.3B | 863.8M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 42.9M | 34.6M | 41.2M | 20.6M | 20.8M |
| Short-term Debt | 738.0K | 974.0K | 823.0K | 354.0K | 11.6M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 41.0M | 12.0M | 15.2M | 125.2M | 5.4M |
| Total Current Liabilities | 333.4M | 240.5M | 187.4M | 247.7M | 90.5M |
| Non-Current Liabilities | |||||
| Long-term Debt | 618.7M | 618.5M | 616.1M | 583.2M | 179.7M |
| Deferred Tax Liabilities | 54.2M | - | - | - | - |
| Other Non-Current Liabilities | 131.1M | 10.0M | 8.9M | 20.7M | 108.3M |
| Total Non-Current Liabilities | 804.2M | 651.8M | 647.9M | 626.4M | 308.8M |
| Total Liabilities | 1.1B | 892.3M | 835.3M | 874.1M | 399.3M |
| Equity | |||||
| Common Stock | 718.0K | 709.0K | 699.0K | 689.0K | 677.0K |
| Retained Earnings | 679.5M | 445.9M | 133.5M | -193.2M | -221.2M |
| Treasury Stock | 477.4M | 175.0M | 75.0M | 75.0M | 0 |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.1B | 1.1B | 815.9M | 447.1M | 464.4M |
| Key Metrics | |||||
| Total Debt | 619.4M | 619.4M | 616.9M | 583.5M | 191.3M |
| Working Capital | 566.5M | 1.1B | 898.5M | 429.9M | 145.3M |
Balance Sheet Composition
Lantheus Holdings Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 233.6M | 312.4M | 326.7M | 28.1M | -71.3M |
| Depreciation & Amortization | 70.1M | 64.6M | 60.0M | 47.9M | 42.3M |
| Stock-Based Compensation | 85.6M | 76.4M | 50.5M | 29.3M | 15.9M |
| Working Capital Changes | -35.2M | -44.7M | -90.1M | -138.6M | -31.3M |
| Operating Cash Flow | 398.1M | 463.7M | 292.2M | 216.0M | 40.1M |
| Investing Activities | |||||
| Capital Expenditures | - | - | - | - | - |
| Acquisitions | -585.7M | -83.2M | - | 0 | 0 |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -585.7M | -146.4M | 52.5M | -258.2M | 15.8M |
| Financing Activities | |||||
| Share Repurchases | -300.0M | -100.0M | 0 | -75.0M | 0 |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | 0 | 0 | 557.8M | 0 |
| Debt Repayment | -1.1M | -318.0K | -717.0K | -175.4M | -43.3M |
| Financing Cash Flow | -323.7M | -121.8M | -16.9M | 304.2M | -44.6M |
| Free Cash Flow | 348.6M | 465.1M | 258.7M | 263.4M | 41.8M |
| Net Change in Cash | -511.3M | 195.5M | 327.8M | 261.9M | 11.3M |
Cash Flow Trend
Lantheus Holdings Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
24.30
Forward P/E
13.17
Price to Book
4.91
Price to Sales
3.50
PEG Ratio
-0.04
Profitability Ratios
Profit Margin
15.15%
Operating Margin
19.07%
Return on Equity
21.45%
Return on Assets
9.28%
Financial Health
Current Ratio
2.70
Debt to Equity
57.19
Beta
-0.12
Per Share Data
EPS (TTM)
$3.41
Book Value per Share
$16.87
Revenue per Share
$22.84
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| LNTH | 5.4B | 24.30 | 4.91 | 21.45% | 15.15% | 57.19 |
| Zoetis | 49.8B | 19.58 | 15.04 | 65.99% | 28.24% | 279.59 |
| Haleon Plc - ADR | 42.4B | 18.72 | 1.88 | 10.27% | 15.11% | 52.37 |
| Alkermes plc | 5.6B | 23.71 | 3.09 | 14.72% | 16.37% | 3.85 |
| Amneal | 4.2B | 63.23 | -57.42 | -101.02% | 2.39% | 45,095.52 |
| Indivior PLC | 4.0B | 20.22 | -42.07 | -212.12% | 16.95% | -3.55 |
Financial data is updated regularly. All figures are in the company's reporting currency.






